Airway Microbiome–Metabolite Interactions in Acute Exacerbations of Chronic Airway Diseases
Microbial communities are associated with exacerbations of asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis, but their composition alone does not explain how they influence host injury or protection. This comprehensive review integrates clinical observations and functional experiments, distinguishing stable disease, acute events, and future exacerbation risk. In asthma, microbial associations vary with inflammatory phenotype, while experimental studies link host and microbial metabolic activity to mucus production and immune regulation. In experimental emphysema, Staphylococcus aureus-derived homocysteine promotes neutrophil-associated injury, whereas tryptophan-derived indole-3-acetic acid supports macrophage-mediated epithelial protection. In bronchiectasis, inflammation can intensify during exacerbations without consistent changes in microbial community composition; separate ex vivo experiments show that neutrophil extracellular traps alter mucus properties. Across diseases, the significance of metabolic signals depends on their source, the underlying tissue pathology, and the host pathways through which they act. Associations with exacerbation risk and evidence of treatment benefit address different clinical questions. Future trials should establish whether local metabolic pathway modulation prevents exacerbations or improves recovery in defined patient groups.
Authors
- W. Li
- K.-C. Lu
- Yun Feng (ORCID: https://orcid.org/0000-0001-8198-5240)
- Jisen Tang
- Xiaoyan Hu (ORCID: https://orcid.org/0009-0008-2122-9644)
- HongChen Xiao
- YiFan Lu
- Yanyu Chen
Institutions
- Ruijin Hospital (CN)
Publication Details
- Journal
- Microorganisms
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/microorganisms14112689
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00